Emerging roles of immunostimulatory oral bacteria in periodontitis development

Trends in Microbiology

Volumn 22, Issue 3, 2014, Pages 157-163

  Jiao, Yizu ^a   Hasegawa, Mizuho ^a   Inohara, Naohiro ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Alveolar bone absorption; Innate immunity; Neutrophil recruitment; NOD1; Pathobiont; Periodontitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 4; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; SULFAMETHOXAZOLE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRIMETHOPRIM;

ALVEOLAR BONE LOSS; BACTERIAL GROWTH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; HOST PATHOGEN INTERACTION; IMMUNOSTIMULATION; INFECTION PREVENTION; INFLAMMATION; INNATE IMMUNITY; MICROBIAL ACTIVITY; MOUTH FLORA; NONHUMAN; PERIODONTITIS; PRIORITY JOURNAL; REVIEW; BACTERIAL COLONIZATION; BIOACCUMULATION; DISEASE ACTIVITY; GAMMAPROTEOBACTERIA; GINGIVA DISEASE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS;

BACTERIA (MICROORGANISMS); GAMMAPROTEOBACTERIA; PORPHYROMONAS GINGIVALIS;

ALVEOLAR BONE ABSORPTION; INNATE IMMUNITY; NEUTROPHIL RECRUITMENT; NOD1; PATHOBIONT; PERIODONTITIS;

ALVEOLAR BONE LOSS; ANIMALS; BACTERIA; DISEASE MODELS, ANIMAL; MICE; MOUTH; PERIODONTITIS;

EID: 84896715308     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.12.005     Document Type: Review

References (70)

1. Eke P.I., et al. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J. Dent. Res. 2012, 91:914-920.
2. Darveau R.P. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 2010, 8:481-490.
3. Henderson B., et al. Aggregatibacter (Actinobacillus) actinomycetemcomitans: a triple A* periodontopathogen?. Periodontology 2010, 54:78-105.
4. Socransky S.S., et al. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 1998, 25:134-144.
5. Kolenbrander P.E., et al. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol. 2010, 8:471-480.
6. Hajishengallis G., Lamont R.J. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol. Oral Microbiol. 2012, 27:409-419.
7. Darveau R.P., et al. Porphyromonas gingivalis as a potential community activist for disease. J. Dent. Res. 2012, 91:816-820.
8. Paster B.J., et al. Bacterial diversity in human subgingival plaque. J. Bacteriol. 2001, 183:3770-3783.
9. Griffen A.L., et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 2012, 6:1176-1185.
10. Abusleme L., et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 2013, 7:1016-1025.
11. Saito T., et al. Cloning, expression, and sequencing of a protease gene from Bacteroides forsythus ATCC 43037 in Escherichia coli. Infect. Immun. 1997, 65:4888-4891.
12. O'Brien-Simpson N.M., et al. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model. Infect. Immun. 2001, 69:7527-7534.
13. Gibson F.C., et al. Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect. Immun. 2001, 69:7959-7963.
14. Bamford C.V., et al. The chymotrypsin-like protease complex of Treponema denticola ATCC 35405 mediates fibrinogen adherence and degradation. Infect. Immun. 2007, 75:4364-4372.
15. Katz J., et al. Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes. Infect. Immun. 2000, 68:1441-1449.
16. Groeger S., et al. Effects of Porphyromonas gingivalis infection on human gingival epithelial barrier function in vitro. Eur. J. Oral Sci. 2010, 118:582-589.
17. Kuramitsu H.K., et al. Interspecies interactions within oral microbial communities. Microbiol. Mol. Biol. Rev. 2007, 71:653-670.
18. Mazumdar V., et al. Metabolic network model of a human oral pathogen. J. Bacteriol. 2009, 191:74-90.
19. Madden T.E., Caton J.G. Animal models for periodontal disease. Methods Enzymol. 1994, 235:106-119.
20. Graves D.T., et al. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol. 2008, 35:89-105.
21. Baker P.J., et al. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 1994, 39:1035-1040.
22. Polak D., et al. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J. Clin. Periodontol. 2009, 36:406-410.
23. Daep C.A., et al. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Infect. Immun. 2011, 79:67-74.
24. Settem R.P., et al. Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model. Infect. Immun. 2012, 80:2436-2443.
25. Gibson F.C., et al. Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model. Infect. Immun. 2004, 72:2408-2411.
26. Fukada S.Y., et al. iNOS-derived nitric oxide modulates infection-stimulated bone loss. J. Dent. Res. 2008, 87:1155-1159.
27. Baker P.J., et al. Adhesion molecule deficiencies increase Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect. Immun. 2000, 68:3103-33107.
28. Ricklin D., et al. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
29. Sveen K., Skaug N. Bone resorption stimulated by lipopolysaccharides from Bacteroides, Fusobacterium and Veillonella, and by the lipid A and the polysaccharide part of Fusobacterium lipopolysaccharide. Scand. J. Dent. Res. 1980, 88:535-542.
30. Kikuchi T., et al. Cot/Tpl2 is essential for RANKL induction by lipid A in osteoblasts. J. Dent. Res. 2003, 82:546-550.
31. + T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect. Immun. 1999, 67:2804-2809.
32. Tanaka T., et al. Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int. J. Biol. Sci. 2012, 8:1227-1236.
33. Yasuda H., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3597-3602.
34. Kawai T., et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 2006, 169:987-998.
35. Simonet W.S., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
36. + Th-cell-mediated alveolar bone destruction in vivo. Infect. Immun. 2005, 73:3453-3461.
37. Jiao Y., et al. Induction of bone loss by pathobiont-mediated NOD1 signaling in the oral cavity. Cell Host Microbe 2013, 13:595-601.
38. Takeuchi O., et al. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
39. Liang S., et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 2011, 186:869-877.
40. Abe T., et al. Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist. J. Immunol. 2012, 189:5442-5448.
41. Papadopoulos G., et al. Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss. J. Immunol. 2013, 190:1148-1157.
42. Aoyama N., et al. Toll-like receptor-2 plays a fundamental role in periodontal bacteria-accelerated abdominal aortic aneurysms. Circ. J. 2013, 77:1565-1573.
43. Popadiak K., et al. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J. Immunol. 2007, 178:7242-7250.
44. Eskan M.A., et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat. Immunol. 2012, 13:465-473.
45. Masumoto J., et al. NOD1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J. Exp. Med. 2006, 203:203-213.
46. Hasegawa M., et al. Differential release and distribution of NOD1 and NOD2 immunostimulatory molecules among bacterial species and environments. J. Biol. Chem. 2006, 281:29054-29063.
47. Hajishengallis G., et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011, 10:497-506.
48. Rovin S., et al. The influence of bacteria and irritation in the initiation of periodontal disease in germ-free and conventional rats. J. Periodontal Res. 1966, 1:193-204.
49. Bryant C.E., et al. The molecular basis of the host response to lipopolysaccharide. Nat. Rev. Microbiol. 2010, 8:8-14.
50. Jain S., et al. A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis. Infect. Immun. 2013, 81:1277-1286.
51. Masoud H., et al. Investigation of the structure of lipid A from Actinobacillus actinomycetemcomitans strain Y4 and human clinical isolate PO 1021-7. Eur. J. Biochem. 1991, 200:775-781.
52. Lima H.R., et al. The essential role of toll like receptor-4 in the control of Aggregatibacter actinomycetemcomitans infection in mice. J. Clin. Periodontol. 2010, 37:248-254.
53. Takeda K., et al. Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res. 2002, 8:459-463.
54. Fujimoto Y., et al. Peptidoglycan as NOD1 ligand; fragment structures in the environment, chemical synthesis, and their innate immunostimulation. Nat. Prod. Rep. 2012, 29:568-579.
55. Hasegawa M., et al. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J. Immunol. 2011, 186:4872-4880.
56. Schleifer K.H., et al. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 1972, 36:407-477.
57. Hasegawa M., et al. Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development. Infect. Immun. 2010, 78:639-650.
58. Höltje J.V. Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli. Microbiol. Mol. Biol. Rev. 1998, 62:181-203.
59. Nigro G., et al. Muramylpeptide shedding modulates cell sensing of Shigella flexneri. Cell. Microbiol. 2008, 10:682-695.
60. Pradipta A.R., et al. Characterization of natural human nucleotide-binding oligomerization domain protein 1 (NOD1) ligands from bacterial culture supernatant for elucidation of immune modulators in the environment. J. Biol. Chem. 2010, 285:23607-23613.
61. Nair B.C., et al. Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J. Periodontal Res. 1983, 18:40-49.
62. Lino Y., et al. The bone resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Capnocytophaga ochracea isolated from human mouths. Arch. Oral Biol. 1984, 29:59-63.
63. Fujimoto Y., et al. Innate immunomodulation by lipophilic termini of lipopolysaccharide; synthesis of lipid As from Porphyromonas gingivalis and other bacteria and their immunomodulative responses. Mol. Biosyst. 2013, 9:987-996.
64. Burns E., et al. Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J. Immunol. 2006, 177:8296-8300.
65. Travassos L.H., et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004, 5:1000-1006.
66. Chamaillard M., et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 2003, 4:702-707.
67. Rautemaa R., et al. Complement-resistance mechanisms of bacteria. Microbes Infect. 1999, 1:785-794.
68. Garlet G.P., et al. Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect. 2005, 7:738-747.
69. Diaz R., et al. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans. Microb. Pathog. 2006, 40:48-55.
70. Bostanci N., Belibasakis G.N. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS. Microbiol. Lett. 2012, 333:1-9.